Quote from Wyttenbach

Vaccine info:

Pfizer Biontech vaccine failed: Should no longer be used

Moderna : Still some use but only about 50%

J&J: So far a clear leader in effect/protection & safety & costs.

I would no longer tolerate the use of experimental RNA vaccines as we now have more than 2 classic ones with really known low safety issues.

These are filthy lies. Wyttenbach and the other members of the Cult of Death are spreading these lies because they want to show how brilliant they are, and they want to frighten the public into obeying them and their twisted, horrific agenda. They don't care that if they succeeded, they would kill millions more people. I have no idea whether Wyttenbach made up these lies up, or whether he dredged them out of an internet sewer, but in any case this is all completely, utterly, false.

Quote from JedRothwell

These are filthy lies. Wyttenbach and the other members of the Cult of Death are spreading these lies because.....

You are the only member here of "cult death". I do warn all people that got the Pfizer vaccine, that they are no longer protected from the RSA strain that already has broadly entered UK.

This information is from a Pfizer payed study. Please follow the science, not the money !

Quote from JedRothwell

These are filthy lies. Wyttenbach and the other members of the Cult of Death a

uber-Rothwell rhetoric.. please moderators

Had Covid? You May Need Only One Dose of Vaccine, Study Suggests

https://news.google.com/articl…=en-US&gl=US&ceid=US%3Aen

Based on these results, the researchers say, people who have had Covid-19 may need only one shot.

“I think one vaccination should be sufficient,” said Florian Krammer, a virologist at the Icahn School of Medicine at Mount Sinai and an author on the study. “This would also spare individuals from unnecessary pain when getting the second dose and it would free up additional vaccine doses.”

While some scientists agree with his logic, others are more cautious. E. John Wherry, director of the University of Pennsylvania’s Institute for Immunology, said that before pushing for a change in policy, he would like to see data showing that those antibodies were able to stop the virus from replicating. “Just because an antibody binds to a part of the virus does not mean it’s going to protect you from being infected,” he said.

It might also be difficult to identify which people have previously been infected, he said. “Documenting that becomes a really potentially messy public health issue,” he said.

What we know about the South African variant of Covid

https://news.google.com/articl…=en-US&gl=US&ceid=US%3Aen

What do we know about the South African variant of Covid?

The South African variant, like the new UK variant, contains a mutation known as N501Y which is believed to make the virus more contagious than older variants. The South African variant also contains other mutations of concern, including E484K and K417N. These two mutations are thought to explain why the South African variant appears to be better able to evade neutralising antibody responses by the body.

Recent results from the Novavax Covid vaccine trials support this concern: while the vaccine had 95.6% efficacy against the original coronavirus and 85.6% against the UK variant, it had an efficacy of only 60% against the South Africa variant.

Experts say there is, at present, no sign that the South African variant results in more severe disease, or different symptoms.

How widespread is the South African variant in the UK?

On 24 January, the health secretary, Matt Hancock, announced that 77 cases of the South African variant had been detected in the UK, and that these were linked to people entering the country from overseas. On Monday 105 cases of the South African variant were announced.

But Public Health England (PHE) has said that cases are no longer confined to people who have recently entered the country, with 11 cases picked up among those with no such travel history – in other words, the variant is now spreading between people in the community. PHE said the South African variant had been found in such circumstances in eight different areas of England.

Unlike the UK variant, known as B117, which can be identified through PCR tests because of the particular mutations it contains, the South African variant, 501Y.V2, cannot be distinguished from other variants in this way – instead it is spotted by genetic sequencing by the Cog-UK consortium.

This consortium is analysing 5%-10% of swabs, meaning not all cases of the South African variant are spotted, although it is expanding its efforts.

“The numbers that we count are only those ones that we have sequenced, so we will underrepresent how many are out there,” Prof Sharon Peacock, director of Cog-UK, told the Guardian, adding that the team are were sequencing between 15,000 and 20,000 genomes a week.

With just over 232,000 coronavirus genomes sequenced by Cog-UK since they started, that suggests – as a rough estimate – that under 0.05% of cases in the UK have involved the South African variant.

U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests

https://www.npr.org/sections/c…te-covid-19-at-home-tests

The Biden administration has made a $231.8 million deal with an Australian company to boost availability of the first at-home rapid test for the coronavirus, which causes COVID-19 that is available without a prescription. The test, made by Ellume, can send results to a smartphone within 15 minutes of receiving a sample.

The Food and Drug Administration gave emergency authorization to Ellume's rapid test in December, after it showed 96% accuracy in a U.S. clinical study. Those trials included both adults and children of ages 2 years and older.

In a press release, the company said its contract, with the U.S. Defense Department, will help fund construction of Ellume's first manufacturing plant in the U.S. Once completed, it will produce more than 500,000 tests per day, according to the company.

The test uses a relatively short nasal swab to collect a sample. The sample is put into a digital analyzer linked to a smartphone app. In December, the company told NPR that the test would be available for about $30.

In October, the company received a $30 million grant from the U.S. National Institutes of Health Rapid Acceleration of Diagnostics initiative to support clinical testing and manufacture of the test.

The Brazil Variant Is Exposing the World’s Vulnerability

https://amp.theatlantic.com/amp/article/617891/

This is happening in a very unlikely place. Manaus saw a devastating outbreak last April that similarly overwhelmed systems, infecting the majority of the city. Because the morbidity was so ubiquitous, many scientists believed the population had since developed a high level of immunity that would preclude another devastating wave of infection. On the whole, Brazil has already reported the second-highest death toll in the world (though half that of the United States). As the country headed into summer, the worst was thought to be behind it.

Data seemed to support the idea that herd immunity in Manaus was near. In Science this month, researchers mapped the virus’s takeover last year: In April, blood tests found that 4.8 percent of the city’s population had antibodies to SARS-CoV-2. By June, the number was up to 52.5 percent. Since people who get infected do not always test positive for antibodies, the researchers estimated that by June about two-thirds of the city had been infected. By November, the estimate was about 76 percent. In The Lancet this week, a team of Brazilian researchers noted that even if these estimates were off by a large margin, infection on this scale “should confer important population immunity to avoid a larger outbreak.” Indeed, it seemed to. The city was able to largely reopen and remain open throughout its winter with low levels of COVID-19 cases.

4 experts IVERMECTIN

Tm 26. 05 concerning penicillin . Study of 15 cases published (1943?).>>>Penicillin mass production .approved .
1 yr. after that it was distributed to Allied troops in WW2 . No RCTs of hundreds/thousands required

Quote from RobertBryant

uber-Rothwell rhetoric.. please moderators

The young Padawan has learned his CNN lessons well, what he suggests is chapter 1

From RFK,Jr's "The Defender" ----

Why so much money for vaccines, and so little for antivirals?

New York Times Explains the How But Not the Why Behind Lack of COVID Treatments

- The New York Times explained how the government poured $18.5 billion into experimental,

fast-tracked vaccines, leaving doctors with “woefully few” drugs to treat the sick.

- Dr. Ian Lipkin, director of the Center for Infection and Immunity at Columbia School of

Public Health: “We are not investing as much in tried and true classical sort of methods,

repurposing drugs and strategies that have already been shown to work. Most of our

investment is in things which are sexy, new and patentable.”

https://childrenshealthdefense…ns-lack-covid-treatments/

Early Multidrug Outpatient Treatment of SARS-CoV-2 Infection (COVID-19) and Reduced Mortality Among Nursing Home Residents

- Multi-drug therapy including hydroxychloroquine with one or more anti-infectives,

corticosteroids, and antithrombotic agents can be extended to seniors in the nursing home

setting without hospitalization. Data from nine studies found multidrug regimens relying on

the use of hydroxychloroquine as well as other agents including doxycycline were associated

with a statistically significant and >60% reductions in mortality.

https://www.medrxiv.org/conten…101/2021.01.28.21250706v1

Targeting TGF-b pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal

Accelerates Recovery from Mild-Moderate COVID-19

https://www.medrxiv.org/conten…101/2021.01.24.21250418v1

Polyphenols EGCG and Luteolin Synergistically Inhibit TGF-β

https://journals.plos.org/plos…1371/journal.pone.0109208

Ultra-short-wave diathermy shortens course moderate/severe COVID-19: an RCT

https://www.medrxiv.org/conten…101/2021.01.28.21250163v1

Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells

- includes analysis of some common phytochemicals

- Nine most potent: Panobinostat, LY2835219, Manidipine, Manidipine 2HCL, Ebastine,

Atovaquone, Bedaquiline, Vitamin D3, Amodiaquine

- "The reasons why these compounds are effective in reducing SARS-CoV-2 infection

and replication are unclear, but their low toxicity, absence of cytopathic effects, and

widespread availability (especially for vitamin D3) warrants closer investigation as a

prophylactic measure in the prevention of COVID."

https://www.biorxiv.org/conten…1.01.31.428851v1.full.pdf

Quote from Lou Pagnucco

New York Times Explains the How But Not the Why

Thanks Lou..

A nurse practioner NP, MSN explains the ..WHY

Lyn Redwood has personal experience with the Bigpharma-NIH-FDA huddle..

https://childrenshealthdefense…thors/lyn-redwood-rn-msn/

"the answer lies in FDA regulations for approving a drug, including a COVID vaccine, for emergency use.

Section 564 §360bbb-3 of the Federal Food, Drug, and Cosmetic Act

states that the FDA commissioner may allow unapproved medical products..to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases

only when “there is no adequate, approved, and available alternative to the product for diagnosing, preventing, or treating such disease or condition.”

In other words, if non-vaccine therapeutics for COVID, such as vitamin C, vitamin D, zinc or the inexpensive treatment protocol developed by the Front Line COVID-19 Critical Care Alliance had been approved as viable treatments for COVID,

the experimental mRNA Moderna and Pfizer vaccines wouldn’t have been eligible for Emergency Use Authorization by the FDA.

"instead, Moderna and Pfizer would have been required to go through the normal licensing procedure for vaccines, including more extensive safety testing."

"NIAID, which operates under the National Institutes of Health (NIH) and is directed by Dr. Anthony Fauci, is a joint patent holder with Moderna on its COVID vaccine. Through royalties, Fauci’s agency and employees stand to profit immensely."

Quote from RobertBryant

4 experts IVERMECTIN

Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments

Chamie-Quintero, Juan and Hibberd, Jennifer and Scheim, David, s (January 12, 2021). Available at SSRN: https://ssrn.com/abstract=3765018 or http://dx.doi.org/10.2139/ssrn.3765018

https://papers.ssrn.com/sol3/D…bstractid=3765018&mirid=1

The Mystery Of India's Plummeting COVID-19 Cases

https://www.npr.org/sections/g…plummeting-covid-19-cases

Last September, India was confirming nearly 100,000 new coronavirus cases a day. It was on track to overtake the United States to become the country with the highest reported COVID-19 caseload in the world. Hospitals were full. The Indian economy nosedived into an unprecedented recession.

But four months later, India's coronavirus numbers have plummeted. Late last month, on Jan. 26, the country's Health Ministry confirmed a record low of about 9,100 new daily cases — in a country of nearly 1.4 billion people. It was India's lowest daily tally in eight months. On Monday, India confirmed about 11,000 cases.

"It's not that India is testing less or things are going underreported," says Jishnu Das, a health economist at Georgetown University. "It's been rising, rising — and now suddenly, it's vanished! I mean, hospital ICU utilization has gone down. Every indicator says the numbers are down."

Scientists say it's a mystery. They're probing why India's coronavirus numbers have declined so dramatically — and so suddenly, in September and October, months before any vaccinations began.

New strains of coronavirus create potential for spring surge, Utah doctors say

https://www.ksl.com/article/50…ng-surge-utah-doctors-say

If coronavirus variants now spreading throughout the United States become dominant strains, health experts fear the potential for a springtime surge.

That's why the speed of the vaccine campaign and public health protective measures are so important.

On Jan. 15, the Utah Department of Health confirmed the first case of the B.1.1.7 COVID-19 variant in Utah, referred to as the "U.K. variant," through ongoing genetic sequencing of positive COVID-19 samples.

According to Dr. Eddie Stenehjem, an infectious disease doctor at Intermountain Healthcare, Utahns need to keep up the personal protective measures until the vaccine makes an impact.

"From an epidemiology standpoint, we are moving in the right direction, and we need to make sure that we keep doing what we're doing," said Stenehjem.

While Utah's critical COVID-19 numbers are currently headed in the right direction, Stenehjem said the variants could change that.

"It's definitely a concern of ours to be really monitoring this current situation with the viral variants," he said. "It just emphasizes the fact that we need to get vaccines out because it looks like the vaccines are protective against these variants."

Is Lung Jelly in COVID-19 Hyaluronan, Opening Door for Treatment?

https://www.medscape.com/viewarticle/939340

We have for the first time demonstrated a striking presence of hyaluronan in alveolar spaces of the lungs in lethal cases of COVID-19," say Urban Hellman, PhD, Department of Public Health and Clinical Medicine, Umeå University, Sweden, and colleagues, in research published recently in the Journal of Biological Chemistry.

They studied lung samples obtained at autopsy from severe COVID-19 victims and compared these with lung tissue from people undergoing thoracic surgery. They found that the alveolar spaces in patients with COVID-19 were filled with exudate that stained heavily for HA, which disappeared when it was exposed to an enzyme that breaks down the polysaccharide.

"There are already therapies that either slow down the body's production of this jelly or break down the jelly through an enzyme," said Hellman in a press release from Umeå University.

"Based on this novel finding, adjuvant treatment targeting hyaluronan may be a promising approach to reduce mortality in critically ill COVID-19 patients," such as the antispasmodic hymecromone, which slows down the production of hyaluronan, the authors speculate.

They add, however, "Clinical randomized trials are warranted to evaluate the safety and efficacy of these substances in the case of severe COVID-19."

NIH study shows hyaluronan is effective in treating chronic lung disease

https://www.nih.gov/news-event…ting-chronic-lung-disease

Researchers at the National Institutes of Health and their collaborators found that inhaling unfragmented hyaluronan improves lung function in patients suffering from severe exacerbation of chronic obstructive pulmonary disease (COPD). Hyaluronan, a sugar secreted by living tissue that acts as a scaffold for cells, is also used in cosmetics as a skin moisturizer and as a nasal spray to moisturize lung airways. Utilized as a treatment, hyaluronan shortened the amount of time COPD patients in intensive care needed breathing support, decreased their number of days in the hospital, and saved money by reducing their hospital stay.

The study, published online in Respiratory Research, is a good example of how examining the impacts of environmental pollution on the lungs can lead to viable treatments. Several years ago, co-senior author Stavros Garantziotis, M.D., medical director of the Clinical Research Unit at the National Institute of Environmental Health Sciences (NIEHS), part of NIH, showed that exposure to pollution causes hyaluronan in the lungs to break down into smaller fragments. These fragments irritate lung tissue and activate the immune system, leading to constriction and inflammation of the airways. He determined that inhalation of healthy, unfragmented hyaluronan reduces inflammation by outcompeting the smaller hyaluronan fragments.

COVID-19 precautions may be reducing cases of flu and other respiratory infections

https://www.sciencenews.org/ar…tory-infections-cases/amp

Heading into the dead of winter, doctors and scientists have noticed something odd: Missing cases of non-COVID-19 respiratory illnesses, specifically flu and respiratory syncytial virus, or RSV.

“We’re seeing very low numbers of both of these infections, even now, while we’re in the peak season,” says Rachel Baker, an epidemiologist at Princeton University. “We really should be seeing cases go up.”

Instead, positive flu tests reported in December are a little less than one one-hundredth of all of those tallied in December 2019, according to data from the U.S. Centers for Disease Control and Prevention. RSV’s drop in reported cases — to one two-hundredth of those a year earlier — is even bigger.

This dramatic dip is probably due to COVID-19 precautions. The same handwashing and social distancing that can prevent the spread of SARS-CoV-2, the virus that causes COVID-19, can prevent the spread of other viruses and pathogens. But that could mean trouble ahead. A lack of cases ironically leads to a growing population susceptible to infection, so future outbreaks could be larger and more unpredictable.

The Mystery Of India's Plummeting COVID-19 Cases

https://www.npr.org/sections/g…plummeting-covid-19-cases

Last September, India was confirming nearly 100,000 new coronavirus cases a day. It was on track to overtake the United States to become the country with the highest reported COVID-19 caseload in the world. Hospitals were full. The Indian economy nosedived into an unprecedented recession.

But four months later, India's coronavirus numbers have plummeted. Late last month, on Jan. 26, the country's Health Ministry confirmed a record low of about 9,100 new daily cases — in a country of nearly 1.4 billion people. It was India's lowest daily tally in eight months. On Monday, India confirmed about 11,000 cases.

"It's not that India is testing less or things are going underreported," says Jishnu Das, a health economist at Georgetown University. "It's been rising, rising — and now suddenly, it's vanished! I mean, hospital ICU utilization has gone down. Every indicator says the numbers are down."

Scientists say it's a mystery. They're probing why India's coronavirus numbers have declined so dramatically — and so suddenly, in September and October, months before any vaccinations began.

They're trying to figure out what Indians may be doing right and how to mimic that in other countries that are still suffering.

I sent the author of the article a copy of hope-simpson study

UK coronavirus variant gets nastier as South African variant spreads

https://www.newscientist.com/a…-african-variant-spreads/

Coronavirus variants are becoming increasingly concerning as they mutate. Samples of the more transmissible B.1.1.7 coronavirus variant, which was first detected in the UK, have acquired a mutation that will help them evade immune protection – the same mutation already present in the B.1.351 variant in South Africa, which is now spreading worldwide.

Local transmission of the B.1.351 variant has been confirmed in the US, several European countries including the UK, Israel, and much of sub-Saharan Africa. It is not yet clear if B.1.351 is more transmissible but it is certain that it can partly evade immunity from natural infections by other variants and vaccines. The big worry is that it could evolve further and completely evade immunity, undermining vaccination efforts.

Lab studies have shown that a mutation called E484K helps B.1.351 evade antibodies. This same mutation has now been found in 11 B.1.1.7 viruses, according to a UK government document. It does not say when or where these viruses were found.

Read more: Global spread of UK coronavirus variant could overwhelm health systems

Ravindra Gupta at the University of Cambridge and his colleagues have already confirmed that this new B.1.1.7 plus E484K variant is better at evading immune protection. In other words, this is a faster spreading virus that is also better at evading immunity. If it is not stopped, it could outcompete the older B.1.1.7 variant, which has already spread to many countries worldwide.

B.1.351 is also going global despite efforts to halt its spread. On 1 February, the UK announced that it had identified 11 cases of B.1.351 that could not be linked to travel, meaning it is spreading within the local community. The UK government has begun testing people in eight areas of England, regardless of symptoms, in an effort to find and eliminate the variant.

The UK has identified 105 cases of B.1.351 altogether but the rest were linked to travel. Unfortunately, the 11 cases are likely just the tip of the iceberg. The only way to detect the B.1.351 variant is to sequence viral samples, and only around 1 in 20 samples from people who test positive are sequenced. What more, many infected people never get tested.

People entering England are meant to self-isolate for 10 days, but it is clear from the spread of other variants during the summer that this is not effective. Travel from parts of Africa, South America and Portugal has now been banned, and enforced isolation in hotels will be introduced soon.

Quote from Fm1

We have for the first time demonstrated a striking presence of hyaluronan in alveolar spaces of the lungs in lethal cases of COVID-19," say Urban Hellman, PhD, Department of Public Health and Clinical Medicine, Umeå University, Sweden, and colleagues, in research published recently in the Journal of Biological Chemistry.

The lung damage is done by freed iron from hemoglobin. The "jelly" does reduce the lung function (oxygen adsorption) so it's indirect damage reduction by e.g. ventilation that could be avoided..

Not needed with early ivermectin.